Umban, Venerando S.

HRN: 26-27-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/17/2025
11/24/2025
IV
2.25g
Q8
Nonhealing Wound
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose 

Final appropriateness: No  Wrong Dose 

Overall appropriateness: No  Adjust Dose According To EGFR

Intervention



Type of Intervention done:

                    

           


Acceptance: